Alcon Inc. remains a global leader in eye care, benefiting from aging demographics and technological innovation. Learn more ...
In this video from the American Academy of Ophthalmology meeting, Philip J. Ferrone, MD, discusses the TEASE-2 trial results in treating Stargardt disease with gildeuretinol.
Advanced imaging technologies like intraoperative OCT and heads-up displays enhance surgical precision and patient outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback